Skip to main content
Caplight Logo









PushCART Therapeutics, Inc.

PushCART Therapeutics, Inc.

Private
Rockville, MarylandHealthcare & Life Scienceshttps://pushcarttx.com

Last Round

Seed

Jul 10, 2026

Momentum

Top 25%

of companies Caplight tracks

Company Overview

PushCART Therapeutics, Inc. operates in Healthcare & Life Sciences and is based in Rockville, Maryland. It was founded in 2025.

PushCART Therapeutics, Inc. is a biotechnology company that develops cell therapies designed to treat solid tumors by enabling immune cells to penetrate dense fibrosis.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

PushCART Therapeutics, Inc. Comparables

Compare PushCART Therapeutics, Inc. with similar companies based on industry and business-model similarity.

PushCART Therapeutics, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Inceptor Bio
80%
Innovative Cellular Therapeutics
77%
Dispatch Biotherapeutics
76%
Book a demo to see all comparables

For institutional investors. Book with your work email.

PushCART Therapeutics, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 10, 2026
SeedApr 27, 2026
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 10, 2026

    $500K Seed Round raised.

  • Apr 27, 2026

    Completed a Seed funding round.

Book a demo to see all signals

For institutional investors. Book with your work email.

PushCART Therapeutics, Inc. Filings

Explore SEC and related filing metadata, where available.

PushCART Therapeutics, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about PushCART Therapeutics, Inc.'s valuation, stock price, and market status.

Is PushCART Therapeutics, Inc. a public or private company?

PushCART Therapeutics, Inc. is a private company.

What is the current stock price of PushCART Therapeutics, Inc.?

PushCART Therapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks PushCART Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is PushCART Therapeutics, Inc. worth (valuation)?

Valuation information for PushCART Therapeutics, Inc. is not publicly available.

Can I buy PushCART Therapeutics, Inc. stock?

PushCART Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was PushCART Therapeutics, Inc.'s last funding round?

PushCART Therapeutics, Inc.'s most recent funding round was Seed on July 10, 2026.

Who are the main investors in PushCART Therapeutics, Inc.?

Investor information for PushCART Therapeutics, Inc. is not publicly disclosed.

Will PushCART Therapeutics, Inc. IPO soon?

No public IPO plans have been announced for PushCART Therapeutics, Inc..

How can I track PushCART Therapeutics, Inc. secondary market activity?

Caplight tracks bids, offers, and trades in PushCART Therapeutics, Inc.'s shares on secondary markets.

Firmographic Details

HeadquartersRockville, Maryland
Year Founded2025
Last FundingJul 10, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?